In clear-cell renal cell carcinoma (ccRCC), sunitinib-resistant ccRCC cells showed considerably lower death-associated protein kinase 1 (DAPK1) mRNA and protein levels than sunitinib-sensitive ccRCC cells. Here, DAPK1 is linked to clear cell renal carcinoma.